| Primary |
| Rheumatoid Arthritis |
19.0% |
| Type 2 Diabetes Mellitus |
14.3% |
| Anxiety |
11.9% |
| Depression |
11.9% |
| Fibromyalgia |
9.5% |
| Neuralgia |
9.5% |
| Post Herpetic Neuralgia |
7.1% |
| Pain |
4.8% |
| Blood Pressure |
2.4% |
| Cerebrovascular Accident |
2.4% |
| Overdose |
2.4% |
| Product Used For Unknown Indication |
2.4% |
| Tension Headache |
2.4% |
|
| Pancreatitis |
13.6% |
| Urinary Retention |
13.6% |
| Lip Dry |
9.1% |
| Tremor |
9.1% |
| Accidental Drug Intake By Child |
4.5% |
| Constipation |
4.5% |
| Depression |
4.5% |
| Iiird Nerve Paralysis |
4.5% |
| Open Angle Glaucoma |
4.5% |
| Pulmonary Embolism |
4.5% |
| Sensation Of Heaviness |
4.5% |
| Speech Disorder |
4.5% |
| Suicidal Ideation |
4.5% |
| Syncope |
4.5% |
| Vision Blurred |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
|
| Secondary |
| Depression |
14.8% |
| Essential Hypertension |
13.6% |
| Rheumatoid Arthritis |
13.6% |
| Post Herpetic Neuralgia |
10.2% |
| Neuralgia |
8.0% |
| Diabetes Mellitus |
6.8% |
| Drug Use For Unknown Indication |
5.7% |
| Type 2 Diabetes Mellitus |
5.7% |
| Fibromyalgia |
4.5% |
| Bronchiectasis |
3.4% |
| Back Pain |
2.3% |
| Hypertension |
2.3% |
| Agitation |
1.1% |
| Arthralgia |
1.1% |
| Blood Cholesterol |
1.1% |
| Cardiovascular Event Prophylaxis |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Insomnia |
1.1% |
| Prophylaxis |
1.1% |
| Prophylaxis Urinary Tract Infection |
1.1% |
|
| Pancreatitis |
15.8% |
| Strabismus |
15.8% |
| Renal Failure |
10.5% |
| Serotonin Syndrome |
10.5% |
| Tremor |
10.5% |
| Death |
5.3% |
| Drug Level Above Therapeutic |
5.3% |
| Encephalopathy |
5.3% |
| Skin Exfoliation |
5.3% |
| Vision Blurred |
5.3% |
| Visual Disturbance |
5.3% |
| Visual Impairment |
5.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.3% |
| Rheumatoid Arthritis |
12.4% |
| Pain |
9.3% |
| Product Used For Unknown Indication |
9.2% |
| Non-small Cell Lung Cancer |
6.5% |
| Depression |
5.6% |
| Hypertension |
4.4% |
| Osteoporosis |
4.0% |
| Insomnia |
3.3% |
| Neuralgia |
3.3% |
| Diabetes Mellitus |
2.8% |
| Asthma |
2.7% |
| Fibromyalgia |
2.7% |
| Hiv Infection |
2.4% |
| Multiple Myeloma |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Epilepsy |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Myocardial Ischaemia |
1.8% |
| Hyperlipidaemia |
1.6% |
|
| Vomiting |
9.2% |
| Pain |
8.0% |
| Tremor |
8.0% |
| Myocardial Infarction |
6.9% |
| Renal Failure Acute |
6.9% |
| Confusional State |
5.7% |
| Sepsis |
5.7% |
| Death |
4.6% |
| Overdose |
4.6% |
| Tinnitus |
4.6% |
| Urinary Tract Infection |
4.6% |
| Chronic Obstructive Pulmonary Disease |
3.4% |
| Glomerular Filtration Rate Decreased |
3.4% |
| Nausea |
3.4% |
| Pain In Extremity |
3.4% |
| Proctalgia |
3.4% |
| Psychotic Disorder |
3.4% |
| Respiratory Failure |
3.4% |
| Sedation |
3.4% |
| Treatment Noncompliance |
3.4% |
|
| Interacting |
| Product Used For Unknown Indication |
85.7% |
| Parkinson's Disease |
14.3% |
|
| Serotonin Syndrome |
50.0% |
| Therapeutic Response Decreased |
50.0% |
|
